Clearance Summary
Comprehensive Segmental Revision System(SRS) received FDA 510(k) clearance under submission number K223631, sponsored by Biomet Orthopedics. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2023-07-12.
- Submission: K223631
- Applicant / Sponsor: Biomet Orthopedics
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3650
- Decision date: 2023-07-12
Classification & Regulation
This clearance is catalogued under FDA product code KWT and 21 CFR 888.3650, within the Orthopedic review panel as a Class II device.